Related Experiment Video
Updated: Jan 15, 2026
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Who determines the outcome? A three-level meta-analysis on systemic therapy in children and adolescents
Niels Braus1, Christoph Flückiger2, Johanna Wichmann1
1School of Psychology and Psychotherapy, Witten/Herdecke University, Witten, Germany.
Objective:
Systemic therapy (ST) is a well-established treatment approach to reduce symptoms, yet its effects across outcome domains, informants, and assessment methods remain underexplored.
Method:
We conducted a systematic literature review in multiple databases (PsycINFO, Pubmed, Embase, Cochrane CENTRAL), including RCT-studies comparing ST with a psychosocial control treatment for diagnosed children or adolescents. We conducted a three-level meta-analysis. Risk of bias was assessed using an adaptation for psychotherapy.
Results:
Overall, we included 44 studies, 370 effect sizes, and 4617 families. The overall effect size was small but significant (g = .16, CI [.09, .23], p < .0001). Contrary to expectations, informants and assessment methods were no significant moderators. Effects were comparable across outcome domains including family functioning (g = .12), caregivers' psychopathology (g = .12) and patient symptoms (g = .19). Outcomes were mostly based on self-report symptom questionnaires, limiting interpretability.
Conclusion:
Findings support that ST improves family functioning and caregivers' psychopathology, underscoring the need for more diverse outcomes.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

